Glycosylphosphatidylinositol (GPI) anchored prostasin (PSN) is a promising marker for ovarian cancer diagnosis with sensitivity and specificity as high as 92% and 94%, respectively. This evidence concerns the gene PRSS8 and ovarian cancer.